Marrone Bio Innovations Profit Margin

As of the most recent data (March 2022), MBII shows a profit margin of -47.08%. That compares with -37.94% in the prior-year period — down 24.1% year over year. That is below the Materials sector average of 16.96%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MBII's profit margin is now -47.08% (was -37.94%) — a 24.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Marrone Bio Innovations is outperforming or lagging.

The Materials sector average profit margin is about 16.96%. Marrone Bio Innovations is at -47.08%, which is lower that average. That is roughly 377.5% below the sector mean. Use the comparison chart on this page to see how MBII stacks up against individual peers as well.

That compares with -37.94% in the prior-year period — down 24.1% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Marrone Bio Innovations with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Marrone Bio Innovations's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -47.08%) with ownership activity and broader fundamentals.